Ilmn stock price forecast analysts highlight steady genomic

Analysts highlight steady genomic sequencing demand and strategic divestment of Grail, which could boost margins. Near-term volatility is expected due to biotech sector sentiment, but EPS growth forecasts remain in the 6–8% range. Overall, ILMN ranks 4th on our list of the best diagnostics stocks to invest in right now. While we acknowledge the potential of ILMN as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ILMN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . Please try using other words for your search or explore other sections of the website for relevant information. From an industry lens, ilmn stock price forecast benefits from a broader uptick in genomic medicine funding. Analysts expect Illumina’s market share in clinical sequencing to outperform peers during the next two quarters.